Fcγ receptors in health and disease;Receptores Fcγ en salud y enfermedad

Revista de Investigacion Clinica

Volumn 50, Issue 6, 1998, Pages 529-540

  Flores Borja, Fabián ^a   Santiago, Edelmiro ^a   Weiss Steider, Benny ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cytokines; Disease; Fc receptors; Growth factors

Indexed keywords

FC RECEPTOR;

ANIMAL; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; RECEPTORS, IGG;

EID: 0032196067     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Ravetch JV, Luster AD, Weinshank RL, Pavlovec A, Portnoy D, Hulmes J, et al. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 1986; 234:718-25.
2. Uher F, Dobronyi I, Gergel J. IgM-Fc receptor-mediated phagocytosis of rat macrophages. Immunology 1981; 42:419-25.
3. Fanger MW, Push J, Bernier GM. The specificity of receptors for IgA on human peripheral polymorphonuclear cells and monocytes. Cell Immunol 1981; 60:324-34.
4. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 1994; 12:63-84.
5. Conrad DH. FcεRII/CD23: the low affinity receptor of IgE. Annu Rev Immunol 1990; 8:623-45.
6. Spiegelberg HL, Melewicz FM. Fc receptors specific for IgE on subpopulations of human lymphocytes and monocytes. Clin Immunol Immunopathol 1980; 15:424-33.
7. Ross GD, Newman SL. Regulation of macrophage functions by complement, complement receptors, and IgG-Fc receptors. In: Bellanti JA, Herscowitz HB, editors. The Reticuloendothelial system. A comprehensive treatise. Vol 6. Immunology. New York: Plenum Press, 1984:173-200.
8. Wallace PK, Howell AL, Fanger MW. Role of Fcγ receptors in cancer and infectious disease. J Leuk Biol 1994; 55:816-26.
9. Anderson CL. Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J Exp Med 1982; 156:1794-806.
10. Guyre PM, Morganelli PM, Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptor on cultured human mononuclear phagocytes. J Clin Invest 1983; 72:393-7.
11. Jones DH, Looney RJ, Anderson CL. Two distinct classes of IgG Fc receptors on a human monocyte cell line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength. J Immunol 1985; 135:3348-53.
12. Osman N, Kozak CA, McKenzie IFC, Hogarth PM. Structure and mapping of the gene encoding the mouse high affinity FcγRI gene and chromosomal location of the human FcγRI gene. J Immunol 1992; 148:1570-5.
13. Qiu WQ, De Bruin D, Brownstein BH, Pearse R, Ravetch JV. Organization of the human and mouse low-affinity FcγR genes: Duplication and recombination. Science 1990; 248:732-5.
14. Hulett MD, Osman N, McKenzie IFC, Hogarth PM. Chimeric Fc receptors identify functional domains of the murine FcγRI high affinity receptor for IgG. J Immunol 1991; 147:1863-8.
15. Ernst LK, van de Winkel JGJ, Chiu IM, Anderson CL. Three genes for the human high affinity Fc receptor for IgG (FcgRI) encode four distinct transcription products. J Biol Chem 1992; 267:15692-700.
16. Ceuppens JL, Baroja ML, Van Vaecjk F, Anderson CL. A defect in the membrane expression of high affinity 72 kD Fc receptors on phagocytic cells in four healthy subjects. J Clin Invest 1988; 82:571-8.
17. Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14:215-21.
18. Ernst LK, Duchemin AM, Anderson CL. Association of the high-affinity receptor for IgG (FcγRI) with the y subunit of the IgE receptor. Proc Natl Acad Sci USA 1993; 90:6023-7.
19. Miller KL, Duchemin AM, Anderson CL. A novel role for the Fc receptor gamma subunit: Enhancement of Fc gamma R ligand affinity. J Exp Med 1996;183:2227-33.
20. Rosenfeld SI, Looney RJ, Leddy JP, Phipps DC, Abraham GN, Anderson CL. Human platelet Fc receptor for immunoglobulin G: Identification as a 40,000 molecular weight membrane protein shared by monocytes. J Clin Invest 1985; 76:2317-23.
21. Looney RJ, Ryan DH, Takahashi K, Fleit HB, Cohen HJ, Abraham GN, et al. Identification of a second class of IgG Fc receptors on human neutrophils: A 40 kD molecule also found on eosinophils. J Exp Med 1986; 163:826-36
22. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Advances in Immununol 1991; 57:1-127.
23. Kurlander RJ, Baker J. The binding of human immunoglobulin G1 monomer and small covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes. J Clin Invest 1982; 69:1-8.
24. Warmerdam PAM, Van den Herik-Oudijk IE, Parren PW, Westerdaal NA, Van de Winkel JGJ, Capel PJ. Interaction of human FcgIIb1 (CD32) with murine and human IgG subclasses. Int Immunol 1993; 5:239-47.
25. Sammartino I, Webber IM, Hogarth PM, McKenzie IFC, Garson OM. Assisgnment of the genes coding for human FcγRII (CD32) to band q23q24 on chromosome 1. Immunogenetics 1988; 28:380-1.
26. Brooks DG, Qui WQ, Luster AD, Ravetch JV. Structure and expression of a human IgG FcRII (CD32): Functional heterogeneity is encoded by the alternative spliced products of multiple genes. J Exp Med 1989; 170:1369-85.
27. Warmerdam PA, Van de Winkel JGJ, Grosselin EJ, Capel PJA. Molecular basis for a polymorphism of human FcγRII (CD32). J Exp Med 1990; 172:19-25.
28. Warmerdam PAM, Van de Winkel JGJ, Vlug A, Westerdaal NAC, Capel PJA. A single aminoacid in the second Ig-like domain of the human Fcγ receptor II is critical in human IgG2 binding. J Immunol 1991; 147:1338-43.
29. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantitation and clinical relevance. Clin Exp Immunol 1990; 81:357-67.
30. Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol 1988; 141:3478-85.
31. Lanier LL, Cwirla S, Yu G, Testi R, Phillips JH. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science 1989; 246:1611-3.
32. Kurosaki T. Ravetch JV. A single aminoacid substitution in the GPI attachment domain is responsible for the alternative membrane anchoring of FcγRIII(CD16). Nature 1989; 342:805-7.
33. Braakman E, Van de Winkel JGJ, Van Krimpen BA, Jansze M, Bolhuis RLH. CD16 on human γδ T lymphocytes: Expression, function and specificity for mouse IgG-isotypes. Cell Immunol 1993;143:97-107.
34. Huizinga TWJ, Kerst M, Nuyens JH, Vlug A, Kr. von dem Borne AEG, Roos D, et al. Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J Immunol 1989; 142:2359-64.
35. Huizinga TWJ, De Haas M, Kleijer M, Nuijens JH, Roos D, Kr. von dem Borne AEG. Soluble Fey receptor III in human plasma originates from release by neutrophils. J Clin Invest 1990; 86:416-23.
36. Harrison D, Philips JH, Lanier LL Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated FcγRIII (CD16-H). J Immunol 1991;147:3459-65.
37. Ory PA, Goldstein IA, Kwoh EE, Clarkson SB. Characterisation of polymorphic forms of FcRIII on human neutrophils. J Clin Invest 1989; 83:1676-81.
38. Huizinga TWJ, Kleijer M, Tetteroo PAT, Roos D, Kr. von dem Borne AEC. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phosphoinositol-linked Fey receptor III (CD16). Blood 1990; 75:213-7.
39. Trounstine ML, Peltz GA, Issei H, Huizinga TWJ, Kr. von dem Borne AEG, Spits H, et al. Reactivity of cloned, expressed human FcγRIII isoforms with monoclonal antibodies wich distinguish cell-type-specific and allelic forms of FcγRIII. Int Immunol 1990; 2:303-10.
40. Lanier LL, Yu G, Phillips JH. Co-association of CD3γ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 1989; 342:803-6.
41. Kurosaki T, Gander I, Ravetch JV. A subunit common to an IgG Fc receptor and the T cell receptor mediates assembly through different interactions. Proc Natl Acad Sci USA 1991; 88:3837-41.
42. Wirthmueller U, Kurosaki T, Murakami MS, Ravetch JV. Signal transduction by FcγRIII (CD16) is mediated through the γ chain. J Exp Med 1992; 175:1381-90.
43. Kipps TJ, Parham P, Punt J, Herzenberg LA. Importance of immunoglobulin isotype in human antibody dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 1985; 161:1-17.
44. Anderson CL, Looney RJ. Human leukocyte IgG Fc receptors, Immunol Today 1986; 7:264-6.
45. Ravetch JV, Kinet JP. Fc Receptors. Annu Rev Immunol 1991; 9:457-92.
46. Ravetch JV. Fc Receptors: Rubor redux. Cell 1994; 78:553-60.
47. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet JG, et al. Cytoplasmic domain heterogeneity and functions of IgG Fc receptor in B lymphocytes. Science 1992; 256:1008-12.
48. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13 aminoacid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 1994; 368:70-3.
49. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell 1994; 76:519-29.
50. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 1996; 379: 346-9.
51. Rodenwald HR, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and naturall killer cells. Cell 1992; 69:139-50.
52. Leclercq G, Plum J. Expression and function of Fc receptors in the thymus. Critical Revs Immunol 1995; 15:215-33.
53. Heijnen IAFM, Vanvugt MJ, Fanger NA, Graziano RF, Dewit TPM, Hofhuis FMA, et al. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest 1996; 97:331-8.
54. Liu Cl, Gosselin EJ, Guyre PM. Fc gamma RII on human B cells can mediate enhanced antigen presentation. Cell Immunol 1996; 167:188-94.
55. Azzoni L, Anegon I, Calabretta B, Perussia B. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2 stimulated NK cells. J Immunol 1995; 154:491-9.
56. Yoshikawa H, Sakihama T, Nakajima Y, Tasaka K. Coestimulation of fibronectin receptor promotes FcγR-mediated rescue of IL-3-dependent bone marrow-derived cells from apoptosis. J Immunol 1996; 156:1832-40.
57. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR, and FcR-dependent cell activation. Immunity 1995; 3:635-46.
58. Johnson SA, Pleiman CM, Pao L, Schneringer J, Hippen K, Cambier JC. Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. J Immunol 1995; 155:4596-603.
59. Iwashima M, Irving BA, van Oers NSC, Chan AC, Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994; 263:1136-8.
60. Perussia B, Dayton ET, Lazarus R, Fanning V, Trinchieri G. Immune Interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med 1983; 158:1092-113.
61. Nambu M, Morita M, Watanabe H, Uenoyama Y, Kim KM, Tanaka M, et al. Regulation of Fcγ receptor expression and phagocytosis of a human monoblast cell line U937. Participation of cAMP and protein kinase C in the effects of IFN-γ and phorbol ester. J Immunol. 1989; 143:4158-65.
62. Sivo J, Politis AD, Vogel SN. Differential effects of interferon-γ and glucocorticoids on FcγR gene expression on murine macrophages. J Leuk Biol 1993; 54:451-7.
63. Buckle AM, Jayaram Y, Hogg N. Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils. Clin Exp Immunol 1990; 81:339-45.
64. Ruhl S, Pluznik DH. Dissociation of early and late markers of murine myeloid differentiation by interferon-gamma and interleukin-6. J Cell Physiol 1993; 155:130-8.
65. Kerst JM, van de Winkel JGJ, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP, et al. Granulocyte colony-stimulating factor induces hFcγRI (CD64antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 1993; 81:1457-64.
66. Bovolenta C, Gasperini S, Cassatella MA. Granulocyte colony-stimulating factor induces the binding of STAT1 and STAT3 to the IFNγ response region within the promoter of the FcγRI/CD64 gene in human neutrophils.FEBS Letters 1996; 86:239-42.
67. Becker S, Warren MK, Haskill S. Colony-Stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Imuunol 1987; 139:3703-9.
68. Magee DM, Wing EJ, Ampel NM, Waheed A, Shadduck RK. Macrophage colony-stimulating factor enhances the espression of Fc receptors on murine peritoneal macrophages. Immunol 1987; 62:373-8.
69. Santiago E, Mendoza JF, Corona TM, Lopez R, Sanchez L, Mora M, Flores F, Valencia E, Weiss-Steider B. Induction of Fc receptors on murine macrophages and leukemic cells by interleukin-1β. Eur Cytokine Netw 1993; 4: 223-8.
70. Flores BF, Weiss-Steider B, Corona OT, Velázquez NM, Santiago OE. El papel de interleucina-1 en la maduración de los glóbulos blancos. Tópicos de Investigación y Posgrado 1992; 3:19-25.
71. Flores F, Hernández J, Ortíz V, Isibasi A, Weiss B, Santiago E. Modulación de la expresión de los receptores para la fracción Fc de las inmunoglobulinas G (FćR) por factores de crecimiento hematopoyético en líneas de células macrofágicas de ratón. Tópicos de Investigación y Posgrado 1997; 3:157-62.
72. Bigler RD, Khoo M, Lund-Katz S, Scerbo L, Esfahani M. Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis. Proc Natl Acad Sci USA 1990; 87:4981-5.
73. Pan L, Mendel DB, Zurlo J, Guyre PM. Regulation of the steady state level of FcγRI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J Immunol 1990; 145:267-75.
74. Ericson SG, Benoit EN, Mills LE, Fanger MW. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fcγ receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation. Exp Hematol 1994; 22:283-9.
75. Erbe DV, Collins JE, Shen L, Graziano RF, Fanger MW. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immunol 1990; 27:57-67.
76. Welch GR, Wong HL, Wahl SM. Selective induction of FcγRIII on human monocytes by transforming growth factor-β. J Immunol 1990; 144:3444-8.
77. Hartnell A, Kay AB, Wardlaw AJ. IFN-γ induces expression of FcγRIII (CD16) on human eosinophils. J Immunol 1992; 148:1471-8.
78. Boltz-Nitulescu G, Willheim M, Spittler A, Leutmezer A, Tempfer C, Winkler S. Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1α,25-dihydroxyvitamin D3 and cytokines. J Leuk Biol 1995; 58:256-62.
79. Te Velde AA, Klomp JPG, Yard BA, DeVries JE, Figdor CG. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol 1988; 140: 1548-54.
80. Mendel DB, Shen L, Guyre PM. The effect of tumor necrosis factor on three IgG Fc receptors on human neutrophils. Clin Res 1988; 35:460A.
81. Graziano RF, Looney RJ, Shen L, Fanger MW. FcγR-mediated killing by eosinophils. J Immunol 1989; 142:230-5.
82. Koenderman L, Hermans SW, Capel PJ, Van de Winkel JG. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFcγRII, on human eosinophils. Blood 1993; 81:2413-9.
83. Tax WJM, van de Winkel JGJ. Human Fcγ receptor II: a standby receptor activated by proteolysis? Immunol Today 1990; 11:308-10.
84. Van de Winkel JGJ, van Ommen R, Huizinga TWJ, De Raad MAHVM, Tuijnman WB, Groenen PJTA, et al. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG. J Immunol 1989; 143:571-8.
85. Fanger MW, Shen L, Graziano RF, Guyre PM. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989; 10:92-9.
86. Littaua R, Kurane I, Ennis FA. Human IgG FcγRII mediates antibody dependent enhancement of dengue virus infection. J Immunol 1990; 144:3183-6.
87. Caraujo-Jorge T, el Bouhdidi A, Rivera MT, Daeron M, Carlier I, Jorge TA. Trypanosoma cruzi infection in mice enhances the membrane expression of low-affinity Fc receptors for IgG and the release of their soluble forms. Parasite Immunol. 1993; 15:539-46.
88. Osiowy C, Horne D, Anderson R . Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Clin Diagn Lab Immunol. 1994; 1:670-7.
89. Kant A, Advani S, Zingde S. Decreased expression of both Fc gamma RII and Fc gamma RIII mRNA in leukemic granulocytes. Leukemia Res 1996; 19:997-1000.
90. Rijkers GT, Sanders LA, Zegers BJ. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 1993; 5:1-21.
91. Norris CF, Surrey S, Bunin GR, Schwartz E, Buchanan GR, McKenzie SE. Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J Pediatr 1996; 128:813-9
92. Roederer M, Herzenberg LA, Herzenberg LA. Changes in antigens densities on leukocytes subsets correlate with progression of HIV disease. Int Immunol. 1996; 8:1-11
93. Dunne J, Feighery C, Whelan A. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients. Br J Biomed Sci. 1996; 53:263-9.
94. Garcia R, Feijoo E, Guerrero MF, de Gorgolas M, Munoz-Fernandez MA, Fernandez-Cruz E, et al. Immune complexes from HIV-1+ patients contain infectious virus able to infect normal lymphocytes. J Allergy Clin Immunol. 1996; 98:827-30.
95. Takeda A, Tuazon CU, Ennis FA. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988; 242:580-3.
96. Hommes DW, Meenan J, de Haas M, ten Kate FJ, von dem Borne AE, Tytgat GN, et al. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 1996; 38:564-7.
97. Nunes IP, Johannessen AC, Matre R, Norway Kristoffersen T. Epithelial expression of HLA class II antigens and Fc gamma receptors in patients with adult periodontitis. J Clin Periodontol 1994; 21:526-32.
98. Zusman T, Gohar O, Eliassi Y, Avivi Y, Lisanki E, Sautes C. The murine Fc-gamma (Fc gamma) receptot type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells. Int J Cancer 1996; 65:221-9.
99. Tartour E, Pannetier C, Mathiot C, Teillaud JL, Sautes C, Kourilsky P, et al. Prognostic value of cytokine and soluble Fc gamma receptor assays in oncology. Immunol Lett 1995; 44:145-8.
100. Valone FH, Kaufman PA, Guyre PM, Lewis LD, Memoli V, Ernstoff MS, et al. Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu. J Hematother 1995; 4:471-5.
101. Hoover RG, Lary C, Page R, Travis P, Owens R, Flick J, et al. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. J Clin Invest 1995; 95:241-7.
102. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflamatory cascade. Science 1994; 265:1095-8.
103. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood 1993; 81:988-93.
104. Choudhry VP, Kashyap R, Ahlawat S, Pati HP. Vinblastine and danazol therapy in steroid resistant childhood chronic idiopalhic thrombocytopenic purpura. Int J Hematol. 1995; 61:157-62.
105. Moxey-Mims MM, Noble B. Glomerular macrophage phagocytic activity in experimental immune complex nephritis. Kidney Int 1994; 45:1326-32.
106. Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol. 1994; 53:27-36.
107. Szegedi A, Boros P, Chen J, Kaffina M, Bona C, Unkeless JC. An Fc gamma RIII (CD16)-specific autoantibody from a patient with progressive systemic sclerosis. Immunol Lett 1993; 35:69-76.
108. Kastner P, Franke H, Kleinert P, Gunther C, Malberg K, Lobnitz M. Fc receptor mediated immune complex clearance function of the mononuclear phagocyte system in systemic lupus erythematosus. Allerg Immunol 1990; 2:103-10.
109. Song YW, Han CW, Kang SW, Back HJ, Lee EB, Shin CH et al. Abnormal distribution of Fc gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998; 3:421-6.
110. Duits AJ, Bootsma H, Derksen RH, Spronk PE; Kater L; Kallenberg CG et al. Skewed distribution of IgG Fc receptor lia (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 38:1832-6.
111. Szucs G, Kavai M, Kiss E, Csipo I, Szegedi G. Correlation of IgG Fc receptors on granulocytes with serum immune complex level in systemic lupus erythematosus. Scand J Immunol 1995; 5:577-80.
112. Vazquez-Doval J, Sanchez-Ibarrola A. Defective mononuclear phagocyte function in systemic lupus erythematosus: relationship of FcRII (CD32) with intermediate cytoskeletal filaments. J Investig Allergol Clin Immunol 1993; 3: 86-91.
113. Bjerke JR, Tigalonova M, Jensen TS, Matre R. Fc gamma-receptors in skin and serum from patients with psoriasis, before and after therapy. Acta Derm Venereol 1994;186:141-2.
114. De Simone C, Guerriero C, Venier A, Rumi C, Bussa S, Fresu R, et al. Increased polymorphonuclear leukocyte Fc gamma-dependent chemiluminescence in active psoriasis is not related to FcRIII (CD16) receptor expression. Exp Dermatol 1993; 2:89-91.